When too late is too late: timing of CAR T-cell therapy in SLE & lupus nephritis
CAR T-cell therapy has demonstrated the capacity to induce deep, drug-free remissions in patients with severe, refractory systemic lupus erythematosus (SLE), including those with lupus nephritis (LN). These observations challenge long-standing assumpti…